Alice K. Jacobs, MD
Emeritus Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Cardiovascular Medicine

MD, Saint Louis University
BA, State University of New York at Buffalo



Alice K. Jacobs, MD, FACC, FAHA, MSCAI is a Professor of Medicine at Chobanian and Avedisian School of Medicine and served as the Director of the Cardiac Catheterization Laboratories and Interventional Cardiology for 20 years until 2011. She is currently Vice Chair for Clinical Affairs in the Department of Medicine at Boston University Medical Center and maintains an active clinical practice. Dr. Jacobs has led the American Heart Association’s Mission: Lifeline, a community-based, national initiative to develop systems of care for ST-segment elevation myocardial infarction (STEMI) patients and to increase the number of patients with timely access to primary percutaneous coronary intervention. Mission: Lifeline has now expanded to include Out-of-Hospital Cardiac Arrest and Stroke systems of care. Dr. Jacobs served as president of the American Heart Association in 2004-05 and as president of the Association of University Cardiologists in 2011. She is a past chair of the ACC/AHA Task Force on Practice Guidelines. During her tenure, the guidelines process and methodology evolved to include formal systematic evidence reviews, inclusion of patient representatives and lay members on guideline committees, incorporation of an Evidence Grading Tool, and further enhancements to the Class of Recommendation/Level of Evidence schema. Dr. Jacobs is a prior member of CMS MEDCAC and the IOM Committee on Social Security Cardiovascular Disability. Currently, she is the immediate past-chair of the American Board of Internal Medicine Interventional Cardiology Self-Assessment Test Committee, a member of NHLBI Cardiothoracic Surgical Network Protocol Review Committee and a member of the New York State Cardiac Advisory Committee. Her major research interest is in coronary revascularization strategies and sex-based difference in ischemic heart disease.

Expertise includes: Interventional Cardiology; Coronary revascularization; Sex-based differences in cardiovascular disease.

Vice Chair for Clinical Affairs
Boston University Chobanian & Avedisian School of Medicine
Medicine


Member
Boston University
Whitaker Cardiovascular Institute


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment...
08/22/2013 - 06/30/2022 (PI)
Abbott Laboratories


A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous c
05/01/2010 - 04/30/2015 (PI)
Harvard Clinical Research Institute


Gravitas: Gauging Responsivness with a Verify Now Assay-Impact on Thrombsis and Safety
10/01/2008 - 09/30/2012 (PI)
Accumetrics


Xience V Everolimus Eluting Coronary Stent System Post-Approval Study (EECSS)
09/01/2008 - 05/31/2012 (PI)
Abbott Laboratories


Tilarginine Acetate Injection in a Randomized International Study in Unstable AMI Patients / Cardiogenic Shock
07/01/2005 - 06/30/2007 (PI)
Arginox

D.E.S. Cover Registry
04/13/2005 - 04/12/2007 (PI)
Cordis Corporation

The GUARD Trial Saphenous Vein Graft Intervention Using AngioGuard for Reduction of Distal Embolization
11/29/2000 - 12/31/2005 (PI)
Cordis Corporation

Clopidogrel for Reduction of Events During Observation (CREDO)
08/25/2000 - 08/31/2001 (PI)
Sanofi Pharmaceuticals Inc (from Cleveland Clinic Foundation) Bristol-Myers Squibb

XaNADU PCI Pilot Trial
01/22/2001 - 05/31/2001 (PI)
Duke University


Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
06/01/2015 - 05/31/2018 (PI)
Duke University Astrazeneca Pharmace

SILVER-AMI : Risk Stratification in Older Persons with Acute Myocardial Infarction
06/01/2013 - 05/31/2018 (PI)
Yale University NIH-NHLBI
5R01HL115295-04

MASS COMM Trial
08/30/2006 - 06/30/2014 (PI)
Harvard Clinical Research Institute DPH

VIRGO study
04/01/2009 - 05/01/2014 (PI)
Yale University NIH-NHLBI
R01 HL081153

Occluded Artery Trial (OAT)
02/01/2001 - 12/31/2010 (PI)
New York University DHHS
U01 HL62509

Bari 2 Diabetes (BARI 2D) Data Coordinating Center
01/01/2001 - 09/30/2010 (PI)
University of Pittsburgh DHHS
5 U01 HL61744-03

FREEDOM (Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management
06/22/2006 - 12/31/2007 (PI)
Mount Sinai Medical Center NIH-NHLBI
1 R01 HL 071988-01A1

SHOCK II Phase 2 Trial
11/01/2003 - 10/30/2005 (PI)
Arginox Pharmaceuticals NIH-NHLBI

Mechanisms Of Pro Thrombosis I
07/01/2001 - 06/30/2005 (PI)
University of Vermont NIH-NHLBI
1R01HL6914601


Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Elkind MSV, Arnett DK, Benjamin IJ, Eckel RH, Grant AO, Houser SR, Jacobs AK, Jones DW, Robertson RM, Sacco RL, Smith SC, Weisfeldt ML, Wu JC, Jessup M. The American Heart Association at 100: A Century of Scientific Progress and the Future of Cardiovascular Science: A Presidential Advisory From the American Heart Association. Circulation. 2024 Mar 19; 149(12):e964-e985. PMID: 38344851
     
  2. Hannan EL, Wu Y, Harik L, Tamis-Holland J, Jacobs AK, Chikwe J, Cozzens KS, Gaudino M. Coronary artery bypass surgery versus percutaneous interventions for women with multivessel coronary artery disease. J Thorac Cardiovasc Surg. 2023 Dec 14. PMID: 38101766
     
  3. Hannan EL, Zhong Y, Cozzens K, Ling FSK, Jacobs AK, King SB, Tamis-Holland J, Venditti FJ, Berger PB. New York Risk Model and Simplified Risk Score for In-Hospital/30-Day Mortality for Percutaneous Coronary Intervention. Am J Cardiol. 2023 Nov 01; 206:23-30. PMID: 37677879
     
  4. Henry TD, Baron SJ, Jacobs AK. STEMI-Related Mortality: Don't Stop Believin'. J Am Coll Cardiol. 2023 Sep 05; 82(10):1011-1013. PMID: 37648351
     
  5. Hannan EL, Zhong Y, Cozzens K, Jacobs AK, King SB, Tamis-Holland J, Ling FSK, Walford G, Venditti FJ, Berger PB, Rocha R. Ad Hoc Percutaneous Coronary Intervention in Stable Patients With Multivessel or Unprotected Left Main Disease. JACC Cardiovasc Interv. 2023 Jul 24; 16(14):1733-1742. PMID: 37495348
     
  6. Osho A, Fernandes MF, Poudel R, de Lemos J, Hong H, Zhao J, Li S, Thomas K, Kikuchi DS, Zegre-Hemsey J, Ibrahim N, Shah NS, Hollowell L, Tamis-Holland J, Granger CB, Cohen M, Henry T, Jacobs AK, Jollis JG, Yancy CW, Goyal A. Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry. Circulation. 2023 Jul 18; 148(3):229-240. PMID: 37459415
     
  7. Ayalon N, Jacobs AK. Enhancing Regional ST-Segment-Elevation Myocardial Infarction Care: A Shock to the System. Circ Cardiovasc Interv. 2023 Jun; 16(6):e013177.View Related Profiles. PMID: 37339238
     
  8. Hannan EL, Zhong Y, Cozzens K, Osinaga A, Efferen L, Jacobs AK, Ling FSK, Gary W, Venditti FJ, Berger PB, Tamis-Holland J, King SB. Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York. Catheter Cardiovasc Interv. 2023 May; 101(6):980-994. PMID: 37002950
     
  9. Hannan EL, Zhong Y, Cozzens K, Tamis-Holland J, Ling FSK, Berger PB, Venditti FJ, King SB, Jacobs AK. Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality. J Soc Cardiovasc Angiogr Interv. 2023; 2(2):100559. PMID: 39129800; PMCID: PMC11308099; DOI: 10.1016/j.jscai.2022.100559;
     
  10. Jollis JG, Granger CB, Zègre-Hemsey JK, Henry TD, Goyal A, Tamis-Holland JE, Roettig ML, Ali MJ, French WJ, Poudel R, Zhao J, Stone RH, Jacobs AK. Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021. JAMA. 2022 Nov 22; 328(20):2033-2040. PMID: 36335474; PMCID: PMC9638953; DOI: 10.1001/jama.2022.20149;
     
Showing 10 of 422 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 413 publications over 43 distinct years, with a maximum of 28 publications in 2006

YearPublications
19813
19821
19843
19853
19862
19872
19882
19895
199010
199111
199210
19931
19945
19957
19963
19975
19984
199913
20006
200117
200218
200320
200421
200513
200628
200721
200812
200916
201018
201120
201216
201318
201415
201510
20169
20176
201810
20196
20205
20213
20226
20238
20241
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

acute coronary syndromes
angioplasty, percutaneous transluminal
coronary artery disease
Interventional cardiology; Women and heart disease
Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map


Jacobs's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department